Evidence map›Paper›PMID 34476127›Full record

ArticleNeurology. Clinical practice2021

Use of Figurative Language by People With Parkinson Disease to Describe "Off" Periods: Clear as Mud.

Lana M Chahine, Briana Edison, Margaret Daeschler, Bernadette Siddiqi, Catherine Kopil, Connie Marras, Sneha Mantri

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurology. Clinical practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lana M ChahineDepartment of Neurology (LMC, BE), University of Pittsburgh, PA; Georgetown University (MD), Washington, DC; The Michael J. Fox Foundation for Parkinson's Research (BS, CK), New York; The Edmond J Safra Program in Parkinson's Disease (CM), Toronto Western Hospital, University of Toronto, Ontario, Canada; and Department of Neurology (SM), Duke University, Durham, NC.ORCID 0000-0003-2521-7196
Briana EdisonDepartment of Neurology (LMC, BE), University of Pittsburgh, PA; Georgetown University (MD), Washington, DC; The Michael J. Fox Foundation for Parkinson's Research (BS, CK), New York; The Edmond J Safra Program in Parkinson's Disease (CM), Toronto Western Hospital, University of Toronto, Ontario, Canada; and Department of Neurology (SM), Duke University, Durham, NC.
Margaret DaeschlerDepartment of Neurology (LMC, BE), University of Pittsburgh, PA; Georgetown University (MD), Washington, DC; The Michael J. Fox Foundation for Parkinson's Research (BS, CK), New York; The Edmond J Safra Program in Parkinson's Disease (CM), Toronto Western Hospital, University of Toronto, Ontario, Canada; and Department of Neurology (SM), Duke University, Durham, NC.
Bernadette SiddiqiDepartment of Neurology (LMC, BE), University of Pittsburgh, PA; Georgetown University (MD), Washington, DC; The Michael J. Fox Foundation for Parkinson's Research (BS, CK), New York; The Edmond J Safra Program in Parkinson's Disease (CM), Toronto Western Hospital, University of Toronto, Ontario, Canada; and Department of Neurology (SM), Duke University, Durham, NC.
Catherine KopilDepartment of Neurology (LMC, BE), University of Pittsburgh, PA; Georgetown University (MD), Washington, DC; The Michael J. Fox Foundation for Parkinson's Research (BS, CK), New York; The Edmond J Safra Program in Parkinson's Disease (CM), Toronto Western Hospital, University of Toronto, Ontario, Canada; and Department of Neurology (SM), Duke University, Durham, NC.
Connie MarrasDepartment of Neurology (LMC, BE), University of Pittsburgh, PA; Georgetown University (MD), Washington, DC; The Michael J. Fox Foundation for Parkinson's Research (BS, CK), New York; The Edmond J Safra Program in Parkinson's Disease (CM), Toronto Western Hospital, University of Toronto, Ontario, Canada; and Department of Neurology (SM), Duke University, Durham, NC.
Sneha MantriDepartment of Neurology (LMC, BE), University of Pittsburgh, PA; Georgetown University (MD), Washington, DC; The Michael J. Fox Foundation for Parkinson's Research (BS, CK), New York; The Edmond J Safra Program in Parkinson's Disease (CM), Toronto Western Hospital, University of Toronto, Ontario, Canada; and Department of Neurology (SM), Duke University, Durham, NC.ORCID 0000-0003-4556-0522

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objective"Off" periods are characterized by the reemergence of motor and nonmotor symptoms in individuals with Parkinson disease (PD) and often negatively affect daily functioning. Individuals' experiences are diverse and may be difficult to articulate; figurative language is often used by patients to describe such experiences. Our objective was to understand how individuals with PD use figurative language to explain off periods and how experts interpret such expressions.

methodsIndividuals with self-reported PD participating in the online Fox Insight study were invited to participate in a survey about off periods. Those endorsing off periods were asked to describe their experiences with open-ended free-text responses. Instances where any type of figurative language was used were identified and classified into themes. Three movement disorder neurologists reviewed each phrase and specified what symptoms they felt were likely represented.

resultsA total of 109 instances of figurative language phrases were identified across descriptions from 86 patients. Allusions to viscous materials (e.g., mud and cement) and effects of chemicals (e.g., drunkenness) were common (18.35% and 17.43% of phrases, respectively). Most phrases were interpreted by the neurologists as representing motor symptoms, but neurologists agreed on what specific symptom was being referred to for only 42 (38.5%) phrases.

conclusionsTo describe off periods, individuals with PD use various forms of figurative language, but this language is not uniformly interpreted and understood by specialists. Given the subjective interpretation of figurative language, exploring what patients are trying to convey when they use such language is important and could improve patient-physician communication.

Identifiers

PMID34476127
PMCPMC8382437

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.